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The study of enzymes in tumours has been one of the central themes of cancer research for many years. This interest stems from the early discoveries of Warburg (1930) that many kinds of tumours appear to have a specific form of metabolism. Since the ultimate control of metabolism in tissues depends upon the levels of enzyme activity, it was logical to search for possible changes in tumour enzyme content as the primary cause of the alteration in tumour metabolism. A vast literature now exists on the enzymology of many kinds of spontaneous and transplantable tumours of animals (particularly rodents) and of man (Greenstein, 1954; Greenstein, 1956;  Aisenberg, 1961; Busch and Starbuck, 1964; Pitot, 1966; Knox, 1967; Shonk and Boxer, 1967; Wenner, 1967) . One of the most frequently observed differences between a tumour and its homologous normal tissue has been the reduction or loss of enzyme activity or of the responsiveness of an enzyme to its normal regulatory mechanisms. Demonstration of the loss of enzymes and other proteins in tumours led to formulation of the deletion hypothesis of cancer (Miller and Miller, 1947; Potter, 1958) although this concept can no longer be considered tenable.
However, until recently, despite this intensive interest in tumour enzyme activity, it has been difficult to relate the significance of any enzyme changes demonstrated to the histological differentiation of tumours. The principal cause of this has been that in most previous studies efforts were largely directed towards establishing differences in selected enzyme activity between fully established tumours and their homologous normal tissues. Thus, tumours at one stage of histological development only were examined in most cases and any possible differences in enzyme content which might be related to structural variations within a single histogenetic tumour class were not considered. Furthermore, in many studies the choice of enzymes examined was determined on a more or less random rather than on a systematic basis. Sometimes it reflected attempts to establish possible differences in activity of enzymes for diagnostic purposes. More commonly, however, it depended upon the special interests and expertise of the individual investigator or was determined by the reliability of the available analytical methods at the time. Therefore, until fairly recently, any meaningful correlation of enzyme activity with the structural differentiation of tumours has virtually been impossible.
However, in the past several years emphasis has shifted towards a more systematic analysis of related groups of enzymes in histologically graded series of tumours derived from a single organ or tissue. The concentration upon tumours of a single homogeneous cell type, which show varying degrees of histological differentiation, is based on the assumption that tumours most closely resembling their homologous normal tissues of origin are most likely to show the deviation from normal which has the greatest relevance to neoplasia (Farber, 1968) .
The most thoroughly studied tumour system developed to exploit this concept has been derived from the rat liver. In this paper the results of some of these studies will be used to illustrate how the pattern of enzyme and metabolic activity in hepatomas can be related to the extent of their structural differentiation. The implications of these findings for current understanding of the fundamental metabolic changes associated with neoplasia will be discussed.
Rat Hepatoma System
Primary hepatocellular carcinomas can be induced in rats by prolonged feeding for several months with certain carcinogenic aromatic amines. By serial transplantation of some of these tumours in inbred strains of rat a graded system of tumours has been developed in which there is a clear spectrum of histological differentiation and growth rate (Morris, 1963 (Morris, , 1965 Morris and Wagner, 1968 
Enzymes and Differentiation of Hepatomas
In recent years rapid advances have been made in the identification of critical or key enzymes in a number of pathways of intermediary metabolism. Assay of these key enzymes under optimal biochemical conditions reveals the functional phenotype of the cell and reflects its genomic activity at that time. Assessment of the responsiveness of these key enzymes to normal regulatory controls can also be made by the performance of various nutritional and hormonal manipulations (Weber and Lea, 1967) .
A systematic approach of this kind applied to the spectrum of hepatomas has revealed a clear alteration in the pattern of normal hepatic enzyme activity which can be correlated with the degree of structural differentiation and growth rate of the tumours. The principal quantitative changes in the key pathway enzymes of intermediary metabolism have been extensively studied and reviewed by Weber and his associates (Weber, Henry, Wagle, and Wagle, 1964; Weber, 1966; Lea, 1966, 1967; Weber, Queener, and Ferdinandus, 1971; Weber, 1972; Weber, Ferdinandus, Queener, Dunaway, and Trahan, 1972) . A summary only of the principal findings is given here and their papers should be consulted for the original sources of the data on which it is based. In all of the results described the normal adult rat liver serves as the standard with which the hepatoma data are compared.
ENZYMES OF CARBOHYDRATE METABOLISM
Progressive loss of structural differentiation in hepatomas is associated with characteristic but opposing changes in the activity of key enzymes of the synthetic and catabolic pathways of carbohydrate metabolism. Thus, as tumours become less well differentiated there is a proportionate reduction in the activity of key gluconeogenic enzymes (table I) .
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The changes in enzyme activity correlate closely with the overall reduction in rate of gluconeogenesis as measured by the conversion of isotopically labelled pyruvate into lactate. Moreover, alteration in the normal regulation of gluconeogenic enzymes is observed and the pronounced increase in enzyme activity which normally follows glucocorticoid administration is greatly reduced in well differentiated hepatomas whereas in poorly differentiated tumours it is completely absent. Consistent with these findings are the low levels of glycogen in many hepatomas whereas activity of phosphoglucomutase is greatly diminished.
By contrast, the activity of key glycolytic enzymes increases in parallel with the decrease in tumour differentiation (table I) , and the increased rate of glycolysis measured by the production of lactate in tumours corresponds with the increased levels of glycolytic enzymes. However, the rate of glycolysis in some well differentiated ('minimal deviation') tumours is in the same range or lower than that of normal liver, refuting the long-held view that all cancers necessarily exhibit an increased rate of glycolysis (Warburg, 1930 The significance of these changes will be discussed later.
Isozymes in Hepatomas
For some time it has been recognized that many tissue enzymes exist not as pure protein species but in multiple molecular forms or isozymes (Markert and M0ller, 1959) . The various isozymic forms of an enzyme may differ in a number of physical and chemical properties which are thought to have great functional significance (Cahn, Kaplan, Levine, and Zwilling, 1962) . In recent years it has become apparent that many neoplastic tissues may undergo marked shifts in their isozymic content (Criss, 1971) . In certain instances this has been attributed to significant alterations in the metabolic characteristics of the tumour tissues (Goldman, Kaplan, and Hall, 1964; Bird and Mainzer, 1972 Weinhouse, 1970; Weinhouse, 1971; Walker and Potter, 1972 Although the enzymic fluctuations in hepatomas can be correlated also with the growth rate of the tumours, the quantitative shifts in enzyme activity appear to have some specificity for the neoplastic form of proliferation. Thus similar patterns of enzyme activity are not found in the rapidly regenerating liver following partial hepatectomy or in the rapidly growing liver of the neonatal rat. In these circumstances it is possible for liver tissues to undergo rapid proliferation at rates comparable to that of the growth of many hepatomas without severe reduction or loss of groups of enzymes or the failure of operation of whole metabolic pathways (Weber, 1966; Weber et al, 1971; Weber, 1972) . Therefore, whilst it may be reasonable to ascribe some of the enzymic and metabolic changes observed in hepatomas simply to increased rates of cellular replication, it would seem that certain of these at least must have a more fundamental basis in the nature of the neoplastic state.
Whether or not the changes demonstrated in the graded series of hepatomas can be regarded as a general feature of all classes of neoplasm still remains to be established. At present systematic studies of this kind have not been performed with other tumour systems although sporadic attempts have been made to correlate the activity of single or random groups of enzymes with the structural differentiation of certain experimental and human III tumours. Thus, Knox, Horowitz, and Friedell (1969) found in a heterogeneous group of transplantable and primary rat tumours that the level of glutaminase activity increased as the histological differentiation of tumours decreased. A similar correlation was subsequently found for this enzyme with a histologically graded series of rat mammary tumours of spontaneous origin or induced experimentally with chemicals or radiations (Knox, Linder, and Friedell, 1970) . In man, the activity of beta-glucuronidase was found to increase in parallel with decreasing differentiation of cerebral astrocytomas (Allen, 1961 and ; and, in histochemical studies of human colonic carcinomas, Wattenberg (1959) found that as tumour differentiation decreased activity of TPN and DPN diaphorase increased. By contrast, in the same tumours activity of succinic and alpha-glycerophosphate dehydrogenase was reduced. In studies of human prostate cancer, some workers have shown by quantitative histochemical techniques that the level of acid phosphatase activity is reduced as tumour differentiation decreases (Parkin, Bylsma, Torre, Drew, and Madden, 1964) . Other histochqmical studies of human cancers have revealed somewhat conflicting results which may be attributed in part to the methodology employed (Dawson, 1967) .
The measurement of single or random groups of enzymes provides little information regarding their functional role in the metabolism of a tumour. The true significance of fluctuations in enzyme activity can only be assessed when it is possible to relate them to the activities of other cellular enzymes and particularly to those which are components of the same metabolic pathways or utilize common substrates (Shonk and Boxer, 1967) . There is obviously a need, therefore, for systematic analysis of other tumour systems to determine the generality of the hepatoma findings.
Several attempts have been made to formulate the hepatoma phenotype on a rational biochemical basis. To Weber the enzyme and metabolic activity of hepatomas constitutes a definitive pattern at the molecular level which can be explained only in terms of ordered alterations in gene expression. These opinions have been incorporated in the 'molecular correlation concept of neoplasia' (Weber, 1966; Lea, 1966 and Weber, 1972) . Here it is postulated that metabolic homeostasis in tissues is normally maintained by the antagonistic activity of key enzymes regulating the synthetic and catabolic pathways of intermediary metabolism. The key enzymes of each pathway are envisaged as forming separate functional genic units whose coordinated activity regulates the overall balance of metabolism in tissues. In hepatomas it is proposed C. C. Bird that genetically determined alterations in the expression of whole genic units produce changes in the activity of groups of key enzymes with corresponding effects on the balance of metabolism in the pathways concerned. The gradually developing imbalance in the enzyme and metabolic activity of hepatomas can certainly be explained on this basis, although the precise nature of the genetic alterations has not been defined.
A different formulation of a somewhat similar interpretation was stimulated by the apparent reactivation in hepatomas of enzymes characteristic of the fetal or neonatal liver. Initially, it was suggested that synthesis of fetal enzymes was the result of the derepression of genes for fetal proteins (Schapira, Dreyfus, and Schapira, 1963; Schapira, Reuber, and Hatzfeld, 1970) . This concept, however, has been amplified by Potter in what he has termed 'oncogeny as blocked ontogeny' (Potter, 1969; Walker and Potter, 1972) . It was observed that during normal 'ontogeny' in liver the isozymes of the fetal and neonatal rat are gradually replaced by those characteristic of the adult animal. However, the potential for synthesis of certain fetal isozymes is retained by the adult organ and when fully mature hepatocytes are stimulated to undergo cell division they cease production of some of the adult isozymes and revert to production of fetal isozymes. This process has been termed 're-ontogeny'. This phenomenon was related to the processes of cell division irrespective of the initiating cause and the same degree of enzyme dedifferentiation was observed in the regenerating liver after partial hepatectomy as in the nodular precancerous liver following carcinogen administration. However 
